Anthera announces plans for $25 million at-the-market sales agreement

Cowen and Co. conducts deal on a commercially reasonable efforts basis

By Devika Patel

Knoxville, Tenn., Nov. 15 - Anthera Pharmaceuticals, Inc. arranged a $25 million at-the-market sales agreement with Cowen and Co., LLC on Nov. 15, according to an 8-K filed Friday with the Securities and Exchange Commission.

The offering will be conducted on a commercially reasonable efforts basis.

Cowen will be paid a 3% commission.

Anthera, based in Hayward, Calif., is a biopharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.